{"count": 183, "results": [{"_id": "35243827", "pmid": 35243827, "pmcid": "PMC9094470", "title": "Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK Biobank", "journal": "Endocrinol Diabetes Metab", "authors": ["English AR", "Prasad B", "McGuigan DH", "Horigan G", "O'Kane M", "Bjourson AJ", "Shukla P", "Kelly C", "McClean PL"], "date": "2022-05-01T00:00:00Z", "doi": "10.1002/edm2.326", "meta_date_publication": "2022 May", "meta_volume": "5", "meta_issue": "3", "meta_pages": "e00326", "score": 50286.418, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ was also associated with reduced risk of incident @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@T2DM@@@ in both @SPECIES_9606 @@@men@@@ and @SPECIES_9606 @@@women@@@ (p < .0001) in the UKBiobank.", "citations": {"NLM": "English AR, Prasad B, McGuigan DH, Horigan G, O'Kane M, Bjourson AJ, Shukla P, Kelly C, McClean PL. Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK Biobank Endocrinol Diabetes Metab. 2022 May;5(3):e00326. PMID: 35243827", "BibTeX": "@article{35243827, title={Simvastatin is associated with superior lipid and glycaemic control to atorvastatin and reduced levels of incident Type 2 diabetes, in men and women, in the UK Biobank}, author={English AR and Prasad B and McGuigan DH and Horigan G and O'Kane M and Bjourson AJ and Shukla P and Kelly C and McClean PL}, journal={Endocrinol Diabetes Metab}, volume={5}, number={3}, pages={e00326}}"}}, {"_id": "33061398", "pmid": 33061398, "pmcid": "PMC7518786", "title": "Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes", "journal": "Vasc Health Risk Manag", "authors": ["Thongtang N", "Tangkittikasem N", "Samaithongcharoen K", "Piyapromdee J", "Srinonprasert V", "Sriussadaporn S"], "date": "2020-09-21T00:00:00Z", "doi": "10.2147/VHRM.S270751", "meta_date_publication": "2020", "meta_volume": "16", "meta_issue": "", "meta_pages": "367-377", "score": 50267.5, "text_hl": "Effect of Switching from Low-Dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ to High-Dose @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@Atorvastatin@@@ on @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@Glucose@@@ Homeostasis and Cognitive Function in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@", "citations": {"NLM": "Thongtang N, Tangkittikasem N, Samaithongcharoen K, Piyapromdee J, Srinonprasert V, Sriussadaporn S. Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes Vasc Health Risk Manag. 2020;16():367-377. PMID: 33061398", "BibTeX": "@article{33061398, title={Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes}, author={Thongtang N and Tangkittikasem N and Samaithongcharoen K and Piyapromdee J and Srinonprasert V and Sriussadaporn S}, journal={Vasc Health Risk Manag}, volume={16}, pages={367-377}}"}}, {"_id": "37335632", "pmid": 37335632, "pmcid": "PMC10256384", "title": "Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke", "journal": "Medicine (Baltimore)", "authors": ["Hu WS", "Yu TS", "Lin CL"], "date": "2023-06-09T00:00:00Z", "doi": "10.1097/MD.0000000000033907", "meta_date_publication": "2023 Jun 9", "meta_volume": "102", "meta_issue": "23", "meta_pages": "e33907", "score": 50262.418, "text_hl": "We identified @SPECIES_9606 @@@patients@@@ coexisting with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@T2DM@@@, @DISEASE_Acute_Coronary_Syndrome @DISEASE_MESH:D054058 @@@ACS@@@ and @DISEASE_Ischemic_Stroke @DISEASE_MESH:D000083242 @@@AIS@@@ who received @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@-@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment as the case group and the index date was the date of first use of the @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@-@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Hu WS, Yu TS, Lin CL. Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke Medicine (Baltimore). 2023 Jun 9;102(23):e33907. PMID: 37335632", "BibTeX": "@article{37335632, title={Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke}, author={Hu WS and Yu TS and Lin CL}, journal={Medicine (Baltimore)}, volume={102}, number={23}, pages={e33907}}"}}, {"_id": "34836863", "pmid": 34836863, "title": "Genotoxic and cytotoxic assessment of sitagliptin and simvastatin alone and in combination.", "journal": "Pak J Pharm Sci", "authors": ["Majeed Khan H", "Nawaz H", "Aerooj H", "Sharif A"], "date": "2021-09-01T00:00:00Z", "meta_date_publication": "2021 Sep", "meta_volume": "34", "meta_issue": "5(Supplementary)", "meta_pages": "1939-1944", "score": 50258.613, "text_hl": "The findings concluded a non-genotoxic combination of @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ which possess a least @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxic@@@ potential suggesting the safe use of the combination both in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@T2DM@@@ and @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@CHD@@@.", "citations": {"NLM": "Majeed Khan H, Nawaz H, Aerooj H, Sharif A. Genotoxic and cytotoxic assessment of sitagliptin and simvastatin alone and in combination. Pak J Pharm Sci. 2021 Sep;34(5(Supplementary)):1939-1944. PMID: 34836863", "BibTeX": "@article{34836863, title={Genotoxic and cytotoxic assessment of sitagliptin and simvastatin alone and in combination.}, author={Majeed Khan H and Nawaz H and Aerooj H and Sharif A}, journal={Pak J Pharm Sci}, volume={34}, number={5(Supplementary)}, pages={1939-1944}}"}}, {"_id": "36891284", "pmid": 36891284, "pmcid": "PMC9988393", "title": "Sub-gingival delivery of simvastatin and rosuvastatin for treatment of chronic periodontitis with diabetes mellitus: A randomized controlled clinical-radiographic pilot study", "journal": "J Oral Biol Craniofac Res", "authors": ["Sharma P", "Singh A", "Mallapragada S"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.jobcr.2023.02.012", "meta_date_publication": "2023 Mar-Apr", "meta_volume": "13", "meta_issue": "2", "meta_pages": "315-320", "score": 50258.184, "text_hl": "30 @SPECIES_9606 @@@patients@@@ with @DISEASE_Chronic_Periodontitis @DISEASE_MESH:D055113 @@@CP@@@ and @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 DM@@@ were classified into three treatment groups - SRP + placebo, SRP +1.2% @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SMV@@@ and SRP +1.2% @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@RSV@@@. ", "citations": {"NLM": "Sharma P, Singh A, Mallapragada S. Sub-gingival delivery of simvastatin and rosuvastatin for treatment of chronic periodontitis with diabetes mellitus: A randomized controlled clinical-radiographic pilot study J Oral Biol Craniofac Res. 2023 Mar-Apr;13(2):315-320. PMID: 36891284", "BibTeX": "@article{36891284, title={Sub-gingival delivery of simvastatin and rosuvastatin for treatment of chronic periodontitis with diabetes mellitus: A randomized controlled clinical-radiographic pilot study}, author={Sharma P and Singh A and Mallapragada S}, journal={J Oral Biol Craniofac Res}, volume={13}, number={2}, pages={315-320}}"}}, {"_id": "33295884", "pmid": 33295884, "pmcid": "PMC7780958", "title": "Simvastatin profoundly impairs energy metabolism in primary human muscle cells", "journal": "Endocr Connect", "authors": ["Mäkinen S", "Datta N", "Nguyen YH", "Kyrylenko P", "Laakso M", "Koistinen HA"], "date": "2020-11-01T00:00:00Z", "doi": "10.1530/EC-20-0444", "meta_date_publication": "2020 Nov", "meta_volume": "9", "meta_issue": "11", "meta_pages": "1103-1113", "score": 50257.176, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ use is associated with @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@muscular@@@ side effects, and increased risk for @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ (@<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@T2D@@@). ", "citations": {"NLM": "Mäkinen S, Datta N, Nguyen YH, Kyrylenko P, Laakso M, Koistinen HA. Simvastatin profoundly impairs energy metabolism in primary human muscle cells Endocr Connect. 2020 Nov;9(11):1103-1113. PMID: 33295884", "BibTeX": "@article{33295884, title={Simvastatin profoundly impairs energy metabolism in primary human muscle cells}, author={Mäkinen S and Datta N and Nguyen YH and Kyrylenko P and Laakso M and Koistinen HA}, journal={Endocr Connect}, volume={9}, number={11}, pages={1103-1113}}"}}, {"_id": "37111264", "pmid": 37111264, "pmcid": "PMC10144141", "title": "Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus", "journal": "Pharmaceuticals (Basel)", "authors": ["Yu JM", "Chen WM", "Chen M", "Shia BC", "Wu SY"], "date": "2023-03-29T00:00:00Z", "doi": "10.3390/ph16040507", "meta_date_publication": "2023 Mar 29", "meta_volume": "16", "meta_issue": "4", "meta_pages": "", "score": 50256.83, "text_hl": "The current study is the first to demonstrate the order of intensity by which specific statin classes affect mortality in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@: @CHEMICAL_pitavastatin @CHEMICAL_MESH:C108475 @@@pitavastatin@@@ > @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ > @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ > @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ > @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ > @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@ > @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@. ", "citations": {"NLM": "Yu JM, Chen WM, Chen M, Shia BC, Wu SY. Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus Pharmaceuticals (Basel). 2023 Mar 29;16(4):. PMID: 37111264", "BibTeX": "@article{37111264, title={Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus}, author={Yu JM and Chen WM and Chen M and Shia BC and Wu SY}, journal={Pharmaceuticals (Basel)}, volume={16}, number={4}}"}}, {"_id": "36557197", "pmid": 36557197, "pmcid": "PMC9785662", "title": "Effects of SLCO1B1 Genetic Variant on Metabolite Profile in Participants on Simvastatin Treatment", "journal": "Metabolites", "authors": ["Fernandes Silva L", "Ravi R", "Vangipurapu J", "Oravilahti A", "Laakso M"], "date": "2022-11-22T00:00:00Z", "doi": "10.3390/metabo12121159", "meta_date_publication": "2022 Nov 22", "meta_volume": "12", "meta_issue": "12", "meta_pages": "", "score": 50255.934, "text_hl": "Logistic regression was used to calculate incident @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@T2D@@@ among the participants with and without @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment. ", "citations": {"NLM": "Fernandes Silva L, Ravi R, Vangipurapu J, Oravilahti A, Laakso M. Effects of SLCO1B1 Genetic Variant on Metabolite Profile in Participants on Simvastatin Treatment Metabolites. 2022 Nov 22;12(12):. PMID: 36557197", "BibTeX": "@article{36557197, title={Effects of SLCO1B1 Genetic Variant on Metabolite Profile in Participants on Simvastatin Treatment}, author={Fernandes Silva L and Ravi R and Vangipurapu J and Oravilahti A and Laakso M}, journal={Metabolites}, volume={12}, number={12}}"}}, {"_id": "36520527", "pmid": 36520527, "title": "Effects of metformin and simvastatin treatment on ultrastructural features of liver macrophages in HFD mice.", "journal": "Ultrastruct Pathol", "authors": ["Ciric D", "Kravic-Stevovic T", "Bumbasirevic V", "Petricevic S", "Jovanovic S", "Trajkovic V", "Martinovic T"], "date": "2023-01-02T00:00:00Z", "doi": "10.1080/01913123.2022.2156639", "meta_date_publication": "2023 Jan 2", "meta_volume": "47", "meta_issue": "1", "meta_pages": "1-11", "score": 50254.12, "text_hl": "In contrast with untreated HFD-fed animals, @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ droplets were not observed in lysosomes of macrophages in HFD animals treated with @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. These findings provide new insight into the effects of @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on the liver in this experimental model of @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and provide further rationale for implementation of statins in the therapeutic regimens in this disease.", "citations": {"NLM": "Ciric D, Kravic-Stevovic T, Bumbasirevic V, Petricevic S, Jovanovic S, Trajkovic V, Martinovic T. Effects of metformin and simvastatin treatment on ultrastructural features of liver macrophages in HFD mice. Ultrastruct Pathol. 2023 Jan 2;47(1):1-11. PMID: 36520527", "BibTeX": "@article{36520527, title={Effects of metformin and simvastatin treatment on ultrastructural features of liver macrophages in HFD mice.}, author={Ciric D and Kravic-Stevovic T and Bumbasirevic V and Petricevic S and Jovanovic S and Trajkovic V and Martinovic T}, journal={Ultrastruct Pathol}, volume={47}, number={1}, pages={1-11}}"}}, {"_id": "36426391", "pmid": 36426391, "title": "Simvastatin Therapy Increased miR-150-5p : Expression in the Patients with Type 2 Diabetes and COVID-19.", "journal": "Cell Physiol Biochem", "authors": ["AmeliMojarad M", "AmeliMojarad M", "Pourmadian A"], "date": "2022-11-25T00:00:00Z", "doi": "10.33594/000000590", "meta_date_publication": "2022 Nov 25", "meta_volume": "56", "meta_issue": "6", "meta_pages": "685-691", "score": 50253.45, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Therapy Increased miR-150-5p : Expression in the @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ and @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@.", "citations": {"NLM": "AmeliMojarad M, AmeliMojarad M, Pourmadian A. Simvastatin Therapy Increased miR-150-5p : Expression in the Patients with Type 2 Diabetes and COVID-19. Cell Physiol Biochem. 2022 Nov 25;56(6):685-691. PMID: 36426391", "BibTeX": "@article{36426391, title={Simvastatin Therapy Increased miR-150-5p : Expression in the Patients with Type 2 Diabetes and COVID-19.}, author={AmeliMojarad M and AmeliMojarad M and Pourmadian A}, journal={Cell Physiol Biochem}, volume={56}, number={6}, pages={685-691}}"}}]}